Live Breaking News & Updates on Emrah Ilker Ozay

Search jobs
10-Mar-2021
SQZ Biotech to Present Preclinical Data on KRAS Tumor Targets and Next Generation SQZ eAPCs at the American Association for Cancer Research (AACR) 2021 Annual Meeting
WATERTOWN, Mass. (BUSINESS WIRE) SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that its team will present data on the next generation SQZ™ APCs and the broader applicability of the APC platform at the American Association for Cancer Research (AACR) 2021 Annual Meeting being held virtually April 10-15, 2021. SQZ APC is a cell therapy platform that aims to induce powerful antigen specific CD8+ T cell responses. Two posters will highlight the additional functionality of enhanced APCs (eAPCs) and potential patient population expansion by leveraging multiple mRNA based cargos. A third poster describes SQZ APCs in development for additional tumor ....

United States , Howard Bernstein , Carolyne Smith , Rebecca Cohen , Michael Maloney , Emrah Ilker Ozay , Technology To Generate Apcs , Exchange Commission , American Association For Cancer Research , Biotechnologies Company , American Association , Cancer Research , Cell Squeeze , Enhancing Potency , Antigen Presenting Cells , Drive Antigen Specific , Diverse Clinical Applications , Private Securities Litigation Reform Act , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , ஹோவர்ட் பெர்ன்ஸ்டீன் , கரோலின் ஸ்மித் , ரிபேக்க கோஹன் , மைக்கேல் மலோநீ , தொழில்நுட்பம் க்கு ஜெநரேட் பாக்ஸ் , பரிமாற்றம் தரகு ,